Clinical Trial Update: Optimizing Antidepressant Treatment by Genotype-dependent Adjustment of Medication According to the ABCB1 Gene [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating genotype-guided adjustment of antidepressant therapy based on the ABCB1 gene in individuals with major depressive disorder; cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Snippet

Sponsor: HolsboerMaschmeyer NeuroChemie GmbH | Conditions: Major Depression | Phase 4 | Status: UNKNOWN